Calidi Biotherapeutics announces 1-for-10 reverse stock split effective July 15, 2024

Calidi Biotherapeutics, Inc.

Reverse stock split at 1-for-10 ratio effective 12:01 a.m. ET on July 15, 2024.
Common stock to trade on split-adjusted basis under symbol CLDI starting July 15.
No fractional shares issued; fractional shares rounded up to nearest whole share.
Warrants adjusted: public warrants exercisable for 1/10th share at $115/whole share; private warrants exercise price x10.
New CUSIP for common stock: 320703 309; warrants CUSIP unchanged.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.